Health

Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $2.1 Bi...

2026-05-12 22:27 3059

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory lower-risk MDS Dr. Myint, a hematology leader and oncology drug-development executive, joins Halia ...

2026-05-12 20:39 2940

Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI

SUZHOU, China, May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine ("Insilico", 03696.HK). Both parties will leverage their respective core strengths in siRNA drug...

2026-05-12 20:30 3168

Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development

SHANGHAI, May 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a biotechnology company powered by generative artificial intelligence , today announced that the company has entered a strategic collaboration agreement with Suzhou Ribo Life Science Co., Ltd.  ("Ribo", 06938.HK), a ...

2026-05-12 20:30 3158

Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership

The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan

2026-05-12 20:00 2191

New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats

Longitudinal analysis reveals clear gaps in global preparedness against emerging viral threats and future pandemics. CAMBRIDGE, Mass., May 12, 2026 /PRNewswire/ -- New global analysis of antiviral compounds released today has identified a critically thin pipeline of treatments in development tha...

2026-05-12 19:00 2013

HKSH Medical Group Named Asia's first Photon-Counting CT Simulator Reference Site, Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers

HONG KONG, May 12, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and global medical technology leader Siemens Healthineers today signed a collaboration agreement at the "Asia Summit on Global Health", establishing HKSH as Siemens Healthineers' first Photon‑Counting Computed Tomography Simulator ...

2026-05-12 17:31 2831

The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec

SHANGHAI, May 12, 2026 /PRNewswire/ -- In 2026, the surgical robotics industry continues to grow steadily. Recent reports show that both procedure volumes and system deployments are rising consistently.Intuitive Surgical surpassed expectations in its Q1 earnings, in...

2026-05-12 17:12 2851

Shanghai's Medical Device Ecosystem: What Makes It a Global Manufacturing Hub

SHANGHAI, May 12, 2026 /PRNewswire/ -- Producing life-saving medical technology requires more than a single factory. It demands an entire ecosystem of material suppliers, precision engineers, and logistical networks working in perfect harmony. Shanghai delivers exactly this. You can experience t...

2026-05-12 16:32 2380

BGI Genomics joins HGP2 Rare Disease Alliance to Close Rare Disease Care Gap in Asia-Pacific

KUALA LUMPUR, Malaysia, May 12, 2026 /PRNewswire/ -- The HGP2 Rare Disease Alliance of the Asia-Pacific Region (HGP2 RaDiAnce–APAC ) was officially launched in Kuala Lumpur on May 10. YBhg. Datuk Dr. Nor Fariza Binti Ngah, Deputy Director-General of Health...

2026-05-12 16:25 3661

TEDxSugar Hill 2026 Announces Yosi Amram: Beyond IQ and EQ -- The Rise of Spiritual Intelligence

SUGAR HILL, Ga., May 12, 2026 /PRNewswire/ -- Nearly three decades ago, national headlines told a dramatic story: "Individual Inc.'s CEO, Amram, Takes Leave, and Stock Drops." — Wall Street Journal "Founder of Individual takes leave and shares fall 37%." — The New York Times "Yosi Amram, the foun...

2026-05-12 15:00 2335

DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source

A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies SINGAPORE, May 12, 2026 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have de...

2026-05-12 14:59 4358

GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical's Phase III Results Signal Differentiation in Weight Loss Arena

SUZHOU, China, May 12, 2026 /PRNewswire/ -- As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention. Mean weight reduction of 19.3%, waist circumference ...

2026-05-12 14:08 2490

AIA Alta High-Net-Worth Optimal Longevity Index Unveiled

A Market‑First Measure of Longevity Readiness in Health and Wealth The overall Index score stands at 62 out of 100, placing HNW and UHNW families in the "Developing" range, with healthspan readiness lagging behind wealth planning HONG KONG, May 12, 2026 /PRNewswire/ -- AIA Alta, AIA Hong Kong's u...

2026-05-12 12:54 2114

Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology

Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreements include 13 programs with the potential to address significant unmet patient needs and support long‑term growth SHANGHAI and PRINCETON, N.J.,...

2026-05-12 12:27 2712

ScienceSoft Receives Frost & Sullivan's 2025 North America Enabling Technology Leadership Recognition for Advancing Patient Engagement and Telehealth Innovation

ScienceSoft is recognized for enabling real-time patient engagement through AI-driven conversational technologies that streamline telehealth operations and enhance care delivery. SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan

2026-05-12 02:00 3385

NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-05-11 21:16 5632

Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery

BOSTON and HANGZHOU, China, May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results from its Phase 1a study of RNK08954 in the peer-reviewed journal Cancer Discovery. R...

2026-05-11 21:00 4387

HoneyNaps Selected for Korea's 2026 Global ICT Unicorn Program

* First SleepTech company selected for Korea's ICT Unicorn Program * FDA-cleared AI sleep diagnostic solution strengthens global expansion strategy * Simultaneous selection for ICT Unicorn Program and K-VIP boosts U.S. market expansion BOSTON, May 11, 2026 /PRNewswire/ -- HoneyNaps, an AI-po...

2026-05-11 20:00 3284

Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape

NANJING, China, May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads Innovation, Future Forward", the event comprehensively presented the Company's strategic elevation from "mul...

2026-05-11 19:00 3133
12345678 ... 874

Week's Top Stories